Synthetic biology may place huge burden on small farmers, environment

The global value of the synthetic biology market reached 1.6 billion dollars in 2011and it will further grow to 10.8 billion by 2016, increasing at a compound annual growth rate (CAGR) of 45.8 percent.

Haiti’s share of worldwide vetiver exports grew from 40 percent in 2001 to over 60 percent in 2007. But in the wake of the worldwide financial crisis, Haiti has seen a sharp reduction in vetiver exports. The country, which shares the island of Hispaniola with the Dominican Republic, produces about 50 to 60 tonnes of vetiver annually, about 50 percent of the world’s supply.

An estimated 60,000 people in Haiti’s Les Cayes region depend on vetiver as their primary income source. The crop is grown on 10,000 hectares.

However, struggling Haitians who farm this product could be dealt another harsh blow with the introduction of a new industry – synthetic biology. Although still undefined, synthetic biology can be described as ‘extreme genetic engineering,’ and refers broadly to the use of computer-assisted, biological engineering to design and construct new synthetic biological parts, devices and systems, and to redesign existing biological organisms.

Synthetic biology differs from conventional genetic engineering in its technique, scale, and its use of novel and synthetic genetic sequences – raising new risks to biodiversity.

Friends of the Earth International is urging caution and has made several recommendations to the 12th meeting of the Conference of the Parties to the Convention on Biological Diversity (COP 12).

“We are recommending a moratorium on the environmental release and the commercial use of synthetic biology, specifically because of the lack of international regulations and virtual lack of environmental and safety assessments anywhere in the world. We are encouraging the CBD to stand behind the precautionary approach which countries have already agreed to by being signatories to the CBD,” Perls said.

“This is a new and emerging issue and needs to be treated as such. Many of the concerns have to do with the environmental, cultural, social impacts of this new technology, including what would happen if a product like ginseng here in Korea were to be produced using synthetic biology. The impact that it would have on small famers across this country could be immense.

Read full original article: Synthetic Biology Could Open a Whole New Can of Worms

 

 

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic
Screenshot 2026-05-06 at 2.56
Singularity crisis ahead? Can super babies save us from rogue AI geniuses?
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Farmers can talk to plants
Farmers are a major source of misinformation—about farming
Screenshot-2026-04-30-at-2.19.37-PM
5 myths about summer dehydration that could damage your health — or even kill you
Screenshot-2026-05-06-at-2.07.43-PM
Manufacturing a conspiracy: The timeline of how  the White House embraced the fringe claim that scientists are being mysteriously murdered
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
Screenshot 2026-05-06 at 2.19
Vaccine shootout at the CDC 
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.